Emulate

Overview

Emulate, Inc. is a biotechnology company based in Boston, Massachusetts, specializing in the development of advanced organ-on-a-chip technology aimed at improving drug development and safety assessments. Founded in 2013, the company operates within the Business Services industry, particularly focusing on research and development in the biotech and pharmaceutical sectors. Emulate's innovative platforms, such as the Human Liver-Chip, are designed to model human organ responses to various treatments, thereby addressing challenges in predicting treatment efficacy and adverse effects in clinical settings. The company's recent technical report discusses the evaluation of immunotoxicity related to cancer immunotherapy, specifically examining the effects of CD137-induced agonism on liver function. This report highlights the use of a Quad-Culture Liver-Chip that incorporates various human immune cells to better simulate drug-induced liver injury (DILI). Emulate's work aims to enhance the understanding of immunotoxicity and improve the predictive capabilities of in vitro models in drug development processes.

Industry